Anand Rohatgi, M.D.
Cardiovascular Director of Academic Development
Professor

Anand Rohatgi, M.D., M.S.C.S., FACC, FAHA, is a Professor of Medicine in the Department of Internal Medicine’s Division of Cardiology at UT Southwestern Medical Center. He specializes in preventive cardiology.

Dr. Rohatgi earned his medical degree at Duke University School of Medicine. He completed an internal medicine residency at the University of Pennsylvania Health System and a cardiology fellowship at UT Southwestern. He also holds a master’s degree in clinical science from UT Southwestern.

Board certified in cardiovascular disease and internal medicine, he joined the UT Southwestern faculty in 2008.

In addition to his clinical roles, Dr. Rohatgi is the Associate Program Director of UTSW’s Cardiovascular Fellowship, and he serves on several campus committees to enhance clinical research. He is an active CME speaker and has given several invited national talks.

Dr. Rohatgi’s research focuses on the role of novel biomarkers in improving risk prediction for atherosclerosis and coronary artery disease. Specifically, his main area of interest is the role of high-density lipoproteins (HDL) in cardiovascular disease. He also focuses on high-risk populations, including those with diabetes and people of South Asian ancestry.

He is currently the principal investigator of “The Genetic and Molecular Basis of Cholesterol Efflux,” a five-year study funded by the National Institutes of Health (NIH) R01 award, and "Mentoring Patient-Oriented Research in Deep Lipid Phenotyping for Cardiovascular Disease," a five-year study funded by the NIH K24 award. He has received past awards for research from the American Heart Association.

He also is the principal investigator of a five year study "Lipoprotein Metabolism and Excess Cardiometabolic Risk in South Asians" funded by the National Institutes of Health (NIH) R01 award (2022-2027). This grant focused on novel markers of lipids like HDL function in South Asians utilizing the MASALA cohort in the U.S. and the U.K. biobank cohort in Europe.

Dr. Rohatgi serves as a reviewer for a number of publications, including The Lancet, Journal of the American Medical Association, Journal of the American Heart Association, American Journal of Cardiology, and Arteriosclerosis, Thrombosis, and Vascular Biology. He is an Associate Editor for Circulation and on the Editorial Board for the Journal of Clinical Lipidology.

He is a Fellow of both the American College of Cardiology and the American Heart Association and a member of the American College of Physicians, the National Lipid Association, and the American Society of Preventive Cardiology, among other professional organizations. He also chairs the board of directors of the nonprofit Texas Loves Children.

Medical School

Duke University School of Medicine (2002)

Residency

University of Pennsylvania Health System (2005), Internal Medicine

Fellowship

UT Southwestern Medical Center (2008), Cardiology

• Biomarkers for Atherosclerosis and Coronary Artery Disease
• High-density Lipoprotein
• Inflammation and Atherosclerosis

Featured Publications

Molecular Patterns of Extreme and Persistent Cholesterol Efflux Capacity.

El-Ghazali A, Deodhar S, Saldanha S, Smyth B, Izbrand M, Gangwar A, Pahlavani M, Rohatgi A, Arterioscler Thromb Vasc Biol 2021 Oct 41 10 2588-2597

HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research.

Rohatgi A, Westerterp M, von Eckardstein A, Remaley A, Rye KA, Circulation 2021 Jun 143 23 2293-2309

Effect of Anacetrapib on Cholesterol Efflux Capacity: A Substudy of the DEFINE Trial.

Metzinger MP, Saldanha S, Gulati J, Patel KV, El-Ghazali A, Deodhar S, Joshi PH, Ayers C, Rohatgi A, J Am Heart Assoc 2020 12 9 24 e018136

Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease.

Ajufo E, Ayers CR, Vigen R, Joshi PH, Rohatgi A, de Lemos JA, Khera A, JAMA Cardiol 2020 Oct

Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and Ethnicity: A Pooled Cohort Analysis.

Singh K, Chandra A, Sperry T, Joshi PH, Khera A, Virani SS, Ballantyne CM, Otvos JD, Dullaart RPF, Gruppen EG, Connelly MA, Ayers CR, Rohatgi A, Circulation 2020 Aug 142 7 657-669

HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events.

Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR, Wedin KE, Neeland IJ, Yuhanna IS, Rader DR, de Lemos JA, Shaul PW N. Engl. J. Med. 2014 Nov

Stressing the Endothelium to Assess Localized Inflammatory Potential and the Risk for Atherosclerotic Cardiovascular Disease.

Rohatgi A, Circulation 2021 May 143 20 1946-1948

Cholesterol efflux capacity and its association with prevalent metabolic syndrome in a multi-ethnic population (Dallas Heart Study).

Akinmolayemi O, Saldanha S, Joshi PH, Deodhar S, Ayers CR, Neeland IJ, Rohatgi A, PLoS One 2021 16 9 e0257574

Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk.

Mehta A, Virani SS, Ayers CR, Sun W, Hoogeveen RC, Rohatgi A, Berry JD, Joshi PH, Ballantyne CM, Khera A, J. Am. Coll. Cardiol. 2020 Aug 76 7 781-793

Impaired HDL Metabolism Links GlycA, A Novel Inflammatory Marker, with Incident Cardiovascular Events.

Riggs KA, Joshi PH, Khera A, Singh K, Akinmolayemi O, Ayers CR, Rohatgi A, J Clin Med 2019 Dec 8 12

 Featured Books

Lipid Measurements. In Chronic Coronary Artery Disease: A Companion to Braunwald?s Heart Disease

Anand Rohatgi (2018). Elsevier

• Discovery Grant Awardee
  American Heart Association Institute of Precision Medicine (2015)
• Young Investigator Award
  American Association of Cardiologists of Indian Origin (2010)
• Council on Arteriosclerosis, Thrombosis, and Vascular Biology Travel Award for Young Investigators
  (2008)
• Finalist - Cardiovascular Young Investigator?s Forum
  Northwestern University (2008)
• Outstanding Resident Teaching Award
  (2005)

• American Society of Preventive Cardiology (2019)
• American College of Cardiology
• American Heart Association
• Dallas County Medical Society
• National Lipid Association
• Texas Medical Association